NEW YORK, July 17, 2025 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2024 ISS Securities Class Action Services Report. The firm is headquartered at the Empire State Building in New York City and is investigating Waters Corporation (NYSE: WAT ) related to its merger with BD and Company's Biosciences and Diagnostic Solutions. Upon completion of the proposed transaction, existing Waters shareholders are expected to own approximately 60.8% of the combined company. Is …

TEMPLE, Texas--(BUSINESS WIRE)--Fuzzy's Taco Shop, the fast-casual+ restaurant brand known for serving up good vibes, is making its much anticipated return to Temple, TX with a grand reopening celebration on Monday, July 21, 2025. After a devastating tornado hit the Temple community last year, this Fuzzy's restaurant has been perfecting its comeback recipe and is ready to open doors to guests once again. Located at 7425 West Adams Avenue, Suite 110, the reimagined space brings back craveable fl.

Deciding which of Lloyds Banking Group PLC (LSE:LLOY) and NatWest Group PLC (LSE:NWG) is the more profitable bank is "the ultimate question" for City philosophers, said analysts at Keefe, Bruyette and Woods. In a substantial document devoted to answering this question -- acknowledging that greater philosophers and scientists have pondered the ultimate question of life, from Socrates's examination of wisdom and virtue, to Einstein's betterment of humanity and Deep Thought mulling of the ultimate question of life, the universe and everything -- the US broker ended up upgrading its target prices for both lenders.

The case followed revelations that data from millions of Facebook users was accessed by Cambridge Analytica, a now-defunct political consulting firm that worked for Donald Trump's successful presidential campaign in 2016.

In my followup on Takeda Pharmaceutical Co (TAK), I am reaffirming my buy rating from March. Clinical demand in multiple areas, along with an active drug pipeline, could keep driving the top-line despite other big pharma names in this sector. The firm has an attractive balance sheet risk profile, along with proven growth in operating cashflow, but lacks a steady dividend growth long-term or impressive profit margins.

CRWV has had an exciting H1'25 performance, thanks to the recent IPO, the growing demand for its neocloud offerings, and the consequently rich multi-year backlog. The same has been observed in the management's laser focus on delivering growth, through hefty FY2025 capex plans, M&A activities and new investments. Even so, given the likely to be dilutive acquisition and the expensive borrowing costs on its aggressive capex, we may see CRWV report a lumpy bottom-line performance ahead.

At 221K, Initial Jobless Claims are down for the fifth week in a row from near-term highs.

US President Donald Trump has claimed that The Coca-Cola Company (NYSE:KO) will use cane sugar instead of high-fructose corn syrup for its soft drinks produced in the US. In a post on his social media platform Truth Social, Trump wrote: “This will be a very good move by them — You'll see.

CAMDEN, Ark.--(BUSINESS WIRE)--L3Harris Technologies (NYSE: LHX) and Arkansas Gov. Sarah Huckabee Sanders have announced plans to construct an extensive large solid rocket motor (LSRM) production campus at the company's site in Camden. L3Harris is investing nearly half a billion dollars across its major production sites to support solid rocket motor production. “Arkansas is a great place for L3Harris to fortify the domestic solid rocket motor industrial base, with its dedicated workforce and st.

I've sold 84% of my EPR Properties position after strong gains, reallocating to new opportunities for better risk/reward. EPR's valuation gap has closed; the stock now trades at a higher P/AFFO than its 5-year average, making it less attractive for my contrarian investment style. While I trust EPR management and their resilience, the current price no longer fits my high-risk, value-seeking approach.

Laura Martin, Needham analyst, joins CNBC's 'Squawk on the Street' to discuss expectations for Netflix earnings, how generative AI could change the use of capital, and more.

CNBC's Phil LeBeau joins 'Squawk on the Street' with the latest earnings news from GE Aerospace.

Amazon cut jobs in its Amazon Web Services cloud computing unit Thursday, a spokesperson confirmed following a Reuters inquiry. Several groups within AWS were impacted.

United Airlines was bullish on Wednesday about a 'strong finish' to the year as the carrier saw demand begin to rise earlier in the month amid decreased uncertainty.

Mark Zuckerberg and other current and former Meta executives have settled a lawsuit filed by a group of shareholders. They were seeking $8 billion for the damage the executives caused the company by allowing repeated violations of Facebook users' privacy in relation to the Cambridge Analytica scandal.

Tim Spence, Fifth Third Bancorp CEO, joins CNBC's 'Squawk on the Street' to discuss the company's most recent earnings, expectations for commercial loan growth, and much more.

Elevance Health, Inc. (NYSE:ELV ) Q2 2025 Earnings Conference Call July 17, 2025 8:30 AM ET Company Participants Felicia Farr Norwood - Executive VP & President of Government Health Benefits Gail Koziara Boudreaux - President, CEO & Director Mark Bradley Kaye - Executive VP & CFO Morgan Kendrick - Corporate Participant Nathan Allen Rich - Vice President of Investor Relations Peter David Haytaian - Executive VP and President of Carelon & CarelonRx Conference Call Participants Albert J. William Rice - UBS Investment Bank, Research Division Andrew Mok - Barclays Bank PLC, Research Division Ann Kathleen Hynes - Mizuho Securities USA …

Tech giant Amazon.com Inc NASDAQ: AMZN has been in full breakout mode since April's low, and the chart says it's not done yet. Shares are up nearly 40% from that bottom and are now closing in on February's all-time high.

Nova Ltd. is a technology leader in semiconductor metrology, vital for advanced chip production and benefiting from AI, advanced packaging, and global chip investments. Financial health is outstanding: high margins, strong cash position, minimal debt, and excellent capital returns, supporting resilience and future growth. Valuation is stretched, with significant downside risk if growth slows, but catalysts like AI, new factories, and acquisitions justify a premium.

COP trades at less than half the industry average EV/EBITDA, but uncertain output and oil prices cloud the upside.